Freestone Grove Partners’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
Other funds holding SBRA
CIM
Freestone Grove Partners's SBRA Position: Q2 2026 in Review
Freestone Grove Partners reduced its Sabra Healthcare REIT (SBRA) stake by 95% in Q2 2026, selling an estimated $27.6M and leaving 74,058 shares worth $1.44M. The position accounts for 0.01% of the portfolio, ranked #473.
Freestone Grove Partners first reported a position in SBRA in Q4 2025 and has held it in 3 quarters since. The position peaked at $34.9M in Q4 2025. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- Freestone Grove Partners held 74,058 shares of Sabra Healthcare REIT worth $1.44M as of Q2 2026.
- Freestone Grove Partners sold 1,393,635 Sabra Healthcare REIT shares in Q2 2026, an estimated $27.6M.
- Sabra Healthcare REIT made up 0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #473 holding.
- Freestone Grove Partners first reported a position in Sabra Healthcare REIT in Q4 2025 and has held it in 3 quarters since.
- Freestone Grove Partners's Sabra Healthcare REIT position peaked at $34.9M in Q4 2025.
- 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.